112 related articles for article (PubMed ID: 2585143)
1. Bone marrow and serum concentrations of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1 alpha,25-dihydroxyvitamin D in patients with leukemia and normal subjects.
Masuda S; Okano T; Noma K; Hamasaki M; Kobayashi T; Oh H; Yoshida S
J Nutr Sci Vitaminol (Tokyo); 1989 Aug; 35(4):211-23. PubMed ID: 2585143
[TBL] [Abstract][Full Text] [Related]
2. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
3. 1 alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts.
Hyodo H; Kimura A; Nakata Y; Ohta H; Kuramoto A
Int J Hematol; 1993 Apr; 57(2):131-7. PubMed ID: 8388271
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
6. 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and total 24,25-dihydroxyvitamin D in human serum.
Parviainen MT; Savolainen KE; Alhava EM; Mäenpää PH
Ann Clin Res; 1981 Feb; 13(1):26-33. PubMed ID: 6972726
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 (1 alpha(OH)D3)].
Taoka T; Hamamoto T; Okuda Y; Hata Y; Kubota Y; Tanaka T; Irino S; Miyazaki T; Ohbayashi S
Rinsho Ketsueki; 1987 Jun; 28(6):830-8. PubMed ID: 3478504
[No Abstract] [Full Text] [Related]
8. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
10. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.
Stern PH; De Olazabal J; Bell NH
J Clin Invest; 1980 Oct; 66(4):852-5. PubMed ID: 7419722
[TBL] [Abstract][Full Text] [Related]
11. Low serum vitamin D levels are associated with shorter survival after first-line azacitidine treatment in patients with myelodysplastic syndrome and secondary oligoblastic acute myeloid leukemia.
Radujkovic A; Schnitzler P; Ho AD; Dreger P; Luft T
Clin Nutr; 2017 Apr; 36(2):542-551. PubMed ID: 26899917
[TBL] [Abstract][Full Text] [Related]
12. Free 25(OH)D and Calcium Absorption, PTH, and Markers of Bone Turnover.
Aloia J; Dhaliwal R; Mikhail M; Shieh A; Stolberg A; Ragolia L; Fazzari M; Abrams SA
J Clin Endocrinol Metab; 2015 Nov; 100(11):4140-5. PubMed ID: 26312580
[TBL] [Abstract][Full Text] [Related]
13. 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.
Honma Y; Hozumi M; Abe E; Konno K; Fukushima M; Hata S; Nishii Y; DeLuca HF; Suda T
Proc Natl Acad Sci U S A; 1983 Jan; 80(1):201-4. PubMed ID: 6296868
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]].
Irino S; Taoka T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981
[TBL] [Abstract][Full Text] [Related]
15. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
[TBL] [Abstract][Full Text] [Related]
17. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
[TBL] [Abstract][Full Text] [Related]
18. Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone.
Birkenhäger-Frenkel DH; Pols HA; Zeelenberg J; Eijgelsheim JJ; Schot R; Nigg AL; Weimar W; Mulder PG; Birkenhäger JC
J Bone Miner Res; 1995 Feb; 10(2):197-204. PubMed ID: 7754799
[TBL] [Abstract][Full Text] [Related]
19. The kidney as an endocrine organ involved in the function of vitamin D.
DeLuca HF
Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
[TBL] [Abstract][Full Text] [Related]
20. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis.
Haug CJ; Aukrust P; Haug E; Mørkrid L; Müller F; Frøland SS
J Clin Endocrinol Metab; 1998 Nov; 83(11):3832-8. PubMed ID: 9814454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
